Prescription and Other Medication Use in Pregnancy
- PMID: 29630018
- PMCID: PMC5912972
- DOI: 10.1097/AOG.0000000000002579
Prescription and Other Medication Use in Pregnancy
Abstract
Objective: To characterize prescription and other medication use in a geographically and ethnically diverse cohort of women in their first pregnancy.
Methods: In a prospective, longitudinal cohort study of nulliparous women followed through pregnancy from the first trimester, medication use was chronicled longitudinally throughout pregnancy. Structured questions and aids were used to capture all medications taken as well as reasons they were taken. Total counts of all medications taken including number in each category and class were captured. Additionally, reasons the medications were taken were recorded. Trends in medications taken across pregnancy and in the first trimester were determined.
Results: Of the 9,546 study participants, 9,272 (97.1%) women took at least one medication during pregnancy with 9,139 (95.7%) taking a medication in the first trimester. Polypharmacy, defined as taking at least five medications, occurred in 2,915 (30.5%) women. Excluding vitamins, supplements, and vaccines, 73.4% of women took a medication during pregnancy with 55.1% taking one in the first trimester. The categories of drugs taken in pregnancy and in the first trimester include the following: gastrointestinal or antiemetic agents (34.3%, 19.5%), antibiotics (25.5%, 12.6%), and analgesics (23.7%, 15.6%, which includes 3.6%; 1.4% taking an opioid pain medication).
Conclusion: In this geographically and ethnically diverse cohort of nulliparous pregnant women, medication use was nearly universal and polypharmacy was common.
Clinical trial registration: ClinicalTrials.gov, NCT01322529.
Conflict of interest statement
The authors did not report any potential conflicts of interest.
Similar articles
-
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.JAMA Intern Med. 2016 Apr;176(4):473-82. doi: 10.1001/jamainternmed.2015.8581. JAMA Intern Med. 2016. PMID: 26998708 Free PMC article.
-
Profile of Reported Alcohol, Tobacco, and Recreational Drug Use in Nulliparous Women.Obstet Gynecol. 2020 Jun;135(6):1281-1288. doi: 10.1097/AOG.0000000000003826. Obstet Gynecol. 2020. PMID: 32459419 Free PMC article.
-
Predictors of the use of medications before and during pregnancy.Int J Clin Pharm. 2013 Jun;35(3):408-16. doi: 10.1007/s11096-013-9750-7. Epub 2013 Feb 7. Int J Clin Pharm. 2013. PMID: 23386140
-
Concomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness.Maturitas. 2011 Mar;68(3):251-5. doi: 10.1016/j.maturitas.2010.11.017. Epub 2010 Dec 17. Maturitas. 2011. PMID: 21168291 Free PMC article. Review.
-
Frequency and type of medications and vaccines used during pregnancy.Obstet Med. 2016 Mar;9(1):21-7. doi: 10.1177/1753495X15604099. Epub 2015 Sep 30. Obstet Med. 2016. PMID: 27512486 Free PMC article. Review.
Cited by
-
How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review.Lancet Reg Health West Pac. 2023 Oct 10;42:100934. doi: 10.1016/j.lanwpc.2023.100934. eCollection 2024 Jan. Lancet Reg Health West Pac. 2023. PMID: 38357390 Free PMC article. Review.
-
Self-Reported Medication Use Across Racial and Rural or Urban Subgroups of People Who Are Pregnant in the United States: Decentralized App-Based Cohort Study.JMIR Form Res. 2023 Nov 28;7:e50867. doi: 10.2196/50867. JMIR Form Res. 2023. PMID: 38015604 Free PMC article.
-
Biological Pathways Associated with Vitamins in Autism Spectrum Disorder.Neurotox Res. 2023 Dec;41(6):730-740. doi: 10.1007/s12640-023-00674-z. Epub 2023 Oct 21. Neurotox Res. 2023. PMID: 37864660 Review.
-
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.Ther Adv Drug Saf. 2023 Sep 28;14:20420986231200746. doi: 10.1177/20420986231200746. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37780667 Free PMC article. Review.
-
The use, perceptions and knowledge of safety of over-the-counter medications during pregnancy in a Canadian population.Womens Health (Lond). 2023 Jan-Dec;19:17455057231199394. doi: 10.1177/17455057231199394. Womens Health (Lond). 2023. PMID: 37750453 Free PMC article.
References
-
- Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):537–45. - PubMed
-
- Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, et al. Use of over-the-counter medications and herbal remedies in pregnancy. American Journal of Perinatology. 2005 Aug;22(6):321–4. - PubMed
-
- Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003 Apr;188(4):1039–45. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- TL1 TR001107/TR/NCATS NIH HHS/United States
- U10 HD063053/HD/NICHD NIH HHS/United States
- U10 HD063020/HD/NICHD NIH HHS/United States
- U10 HD063072/HD/NICHD NIH HHS/United States
- U10 HD063041/HD/NICHD NIH HHS/United States
- UG1 HD040512/HD/NICHD NIH HHS/United States
- KL2 TR001106/TR/NCATS NIH HHS/United States
- U10 HD063046/HD/NICHD NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- U10 HD063036/HD/NICHD NIH HHS/United States
- U10 HD063047/HD/NICHD NIH HHS/United States
- U10 HD063037/HD/NICHD NIH HHS/United States
- U10 HD063048/HD/NICHD NIH HHS/United States
- UL1 TR000153/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
